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Background
HIV-1 integrase is responsible for the transfer of virally
encoded DNA into the host chromosome. The process of
integration occurs through 3 essential steps: formation of
the preintegration viral DNA complex, 3’processing and
5’ strand transfers. Provirus ancestral pol protein is a
component of preintegration viral DNA complex, which
has reverse transcriptase domain, Ribonuclease H like
domain, integrase, N terminal and Zinc binding domain.
To complete the integration process, strand transfer
should take place. This work involves in silico prediction
of the flavonoids as inhibitors of integrase activity.
Methods
n this experiment, docking studies were performed by
modeling Pol protein: P10266 (HERV-K_5q33.3 provirus
ancestral Pol protein), Q9UQG0 (HERV-K_3q27.3 pro-
virus ancestral Pol protein), Q9BXR3 (HERV-K_7p22.1
provirus ancestral Pol protein) and docking with the fla-
vonoid compound AC1NSUMK, Quercetin 3 arabinoside
and compared with Raltegravir.
Results
Docking studies illustrate the binding between the Pol pro-
tein and flavonoid compound. In docking, the interactions
were found in P10266 with AC1NSUMK at GLN378,
GLN338, GLY283 and TYR375 with -7.71 kcal/mol.
P10266 with Raltegravir at VAL369 and THR371 with
-7.68 kcal/mol binding energy. The binding site resembles
a saddle shape cleft which has positively charged residues.
Conclusion
The protein along with the AC1NSUMK with four
hydrogen bonds proves to be a most stable complex
inhibiting the activity of integrase. The interaction
shows that it binds to the protein and specifically inter-
feres with its strand transfer activity. Hence, this may be
one of the potential candidates for inhibition of HIV
activity.
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